{"database": "lobbying", "table": "lobbying_activities", "rows": [[2060304, "9e271216-a5c0-4f40-96ad-c85e4a8b5d35", "Q4", "FARRAGUT PARTNERS LLP", 401103938, "GENENTECH", 2017, "fourth_quarter", "MMM", "Concerns regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. \nMedicare Part B Demonstration.\nPrescription Drug User Fee Act.\nCHIP reauthorization.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2018-01-11T13:35:12.157000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2060304"], "units": {}, "query_ms": 106.58272204454988, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}